Table 4.
Types of patient attachment (over a two-year period) | All patients | Sex | Age group | Chronic diseases | Morbidity level† | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Female | Male | 20–44 | 45–59 | 60–74 | 75 or over | Diabetes | Low | Moderate | High | ||
(n = 687,680) | (n = 560,569) | (n = 547,257) | (n = 343,368) | (n = 225,610) | (n = 132,014) | (n = 116,657) | (n = 461,851) | (n = 513,623) | (n = 111,324) | ||
% | % | % | % | % | % | % | % | % | % | % | |
FMG enrolment | 7.2 | 8.0 | 6.2 | 6.3 | 8.1 | 7.9 | 7.7 | 8.1 | 6.8 | 7.8 | 8.0 |
Enrolment as vulnerable patient (but not FMG) | 16.2 | 17.7 | 14.4 | 2.9 | 9.5 | 26.7 | 71.2 | 48.4 | 7.4 | 23.5 | 36.9 |
2 CMEs by the same FP, without enrolment | 5.3 | 6.2 | 4.2 | 3.7 | 7.7 | 8.0 | 0.7 | 2.8 | 6.1 | 6.6 | 2.9 |
1 CME with a UPC score ≥75% to the CME FP, without enrolment | 8.1 | 7.9 | 8.3 | 7.7 | 10.7 | 8.8 | 1.6 | 4.5 | 9.5 | 7.4 | 4.4 |
1 CME, without enrolment or UPC score ≥75% to the CME FP | 8.0 | 9.2 | 6.5 | 10.1 | 8.9 | 5.7 | 1.1 | 3.6 | 8.8 | 9.1 | 6.2 |
UPC score ≥75%, without enrolment or CME | 12.7 | 12.3 | 13.2 | 11.1 | 15.6 | 16.6 | 5.2 | 11.8 | 13.0 | 13.6 | 11.0 |
A single visit (not for CME) to an FP, without enrolment | 10.5 | 8.4 | 13.2 | 15.8 | 9.0 | 5.0 | 2.4 | 3.4 | 13.0 | 4.5 | 4.9 |
| |||||||||||
Patients attached to an FP | 68.0 | 69.7 | 66.0 | 57.6 | 69.5 | 78.7 | 89.9 | 82.6 | 64.6 | 72.5 | 74.3 |
| |||||||||||
Patients not attached to an FP | 31.9 | 30.3 | 33.9 | 42.5 | 30.4 | 21.3 | 10.1 | 17.5 | 35.6 | 27.5 | 25.7 |
| |||||||||||
Total | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
†Morbidity level is defined by the RUB (Resource Utilization Band, ACG Case-Mix System), which identifies 5 categories of morbidity with similar expected health services utilization (1: healthy patients; 2: low level of utilization; 3: moderate level of utilization; 4: high level of utilization; and 5: very high level of utilization). Low level of morbidity corresponds to RUB 1 and 2; moderate level of morbidity to RUB 3; and high level of morbidity to RUB 4 and 5.